Bioliberty
PrivateLast Round
Series A
Extension
Nov 2, 2026
Total Funding Raised
$8.7M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Bioliberty operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a Series A Extension round in November 2026.
Bioliberty is a medical technology company that develops soft robotic wearables and a digital therapy platform to assist with patient recovery from mobility-limiting conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Industrial Robotics, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioliberty Comparables
Compare Bioliberty with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GripAble | 88% | |
| Zunosaki Limited | 85% | |
| Syrebo | 84% |
For institutional investors. Book with your work email.
Bioliberty Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 2, 2026 | ||||
| Seed Round | Jul 31, 2026 | ||||
| Series A | Mar 18, 2026 | ||||
| Pre Seed | Jul 1, 2025 | ||||
| Grant | Dec 4, 2023 | ||||
Seed | Apr 4, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bioliberty Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Scottish EDGE | Grant |
| Innovate UK | Grant |
| Old College Capital | Pre Seed, Seed, Series A |
| Ballad Ventures | Series A Extension |
| 25m Health | Series A Extension |
| Scottish National Investment Bank | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
$3.3M round with participation from Ballad Ventures and TGH Ventures.
- Jul 31, 2026
Raised $3M in a Seed Round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_offices_toNov 11, 2026
Bioliberty, Inc. opens a US headquarters in Massachusetts in 2025.
- receives_financingNov 6, 2026
Bioliberty, Inc. raises $3.31M in a Series A1 extension from TGH Ventures, Ballad Ventures, Whiterock, and 25m Health to connect rehabilitation data, expand its technology into the home, and augment therapy and assessment with AI on Nov 6th '26.
- is_developingNov 2, 2026
Bioliberty, Inc. develops soft robotic technology for upper limb rehabilitation, including an interactive therapy system, an air-powered robotic glove, and an AI-enabled clinician dashboard for people recovering from strokes and other neurological conditions.
- receives_financingNov 2, 2026
Bioliberty, Inc. receives an additional $3.3M for its Series A round, backed by TGH Ventures, Ballad Ventures, 25M Health, and Whiterock, to accelerate its U.S. commercial rollout, expand clinical trials, scale teams, and advance therapeutic-hardware manufacturing in United Kingdom on Nov 2nd '26.
- receives_financingAug 24, 2026
Bioliberty, Inc. receives $4.09M in Series A financing to support healthtech innovation with demonstrable income generation.
For institutional investors. Book with your work email.
Bioliberty Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bioliberty's valuation, stock price, and market status.
Is Bioliberty a public or private company?
Bioliberty is a private company.
What is the current stock price of Bioliberty?
Bioliberty is a private company, so its shares have no public market price. Caplight tracks Bioliberty's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bioliberty worth (valuation)?
Valuation information for Bioliberty is not publicly available.
Can I buy Bioliberty stock?
Bioliberty shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bioliberty's last funding round?
Bioliberty's most recent funding round was Series A Extension on November 2, 2026.
Who are the main investors in Bioliberty?
Key investors in Bioliberty include Scottish National Investment Bank, Archangel Investors.
Will Bioliberty IPO soon?
No public IPO plans have been announced for Bioliberty.
How can I track Bioliberty secondary market activity?
Caplight tracks bids, offers, and trades in Bioliberty's shares on secondary markets.